The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report
Open accessAbstract
Newborn screening (NBS) for cystic fibrosis (CF) is increasingly being implemented and is soon likely to be in use throughout the United States, because early detection permits access to specialized medical care and improves outcomes. The diagnosis of CF is not always straightforward, however. The sweat chloride test remains the gold standard for CF diagnosis but does not always give a clear answer. Genotype analysis also does not always provide clarity; more than 1500 mutations have been identified in the CF transmembrane conductance regulator (CFTR) gene, not all of which result in CF. Harmful mutations in the gene can present as a spectrum of pathology ranging from sinusitis in adulthood to severe lung, pancreatic, or liver disease in infancy. Thus, CF identified postnatally must remain a clinical diagnosis. To provide guidance for the diagnosis of both infants with positive NBS results and older patients presenting with an indistinct clinical picture, the Cystic Fibrosis Foundation convened a meeting of experts in the field of CF diagnosis. Their recommendations, presented herein, involve a combination of clinical presentation, laboratory testing, and genetics to confirm a diagnosis of CF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gibson, L. E., & Cooke, R. E. (1959) · Pediatrics · doi:10.1542/peds.23.3.545 · Cited by 1,434
The diagnosis of cystic fibrosis: A consensus statement
Rosenstein, B. J., & Cutting, G. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70344-0 · Cited by 1,086
Self-citationPrediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993
Chloride impermeability in cystic fibrosis
Quinton, P. M. (1983) · Nature · doi:10.1038/301421a0 · Cited by 767
Kerem, E., Corey, M., Kerem, B.-S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L.-C., & Durie, P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232203 · Cited by 728
Self-citationGenetic Modifiers of Lung Disease in Cystic Fibrosis
Drumm, M. L., Konstan, M. W., Schluchter, M. D., Handler, A., Pace, R., Zou, F., Zariwala, M., Fargo, D., Xu, A., Dunn, J. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051469 · Cited by 504
Self-citationWatson, M. S., Cutting, G. R., Desnick, R. J., Driscoll, D. A., Klinger, K., Mennuti, M., Palomaki, G. E., Popovich, B. W., Pratt, V. M., Rohlfs, E. M., et al. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000139506.11694.7c · Cited by 470
Self-citationHighsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Boat, T. E., Spock, A., Gorvoy, J. D., Quittell, L., Friedman, K. J., Silverman, L. M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311503 · Cited by 441
A mutation in CFTR produces different phenotypes depending on chromosomal background
Kiesewetter, S., Macek, M., Davis, C., Curristin, S. M., Chu, C.-S., Graham, C., Shrimpton, A. E., Cashman, S. M., Tsui, L.-C., Mickle, J., et al. (1993) · Nature Genetics · doi:10.1038/ng1193-274 · Cited by 441
Self-citationNutritional Benefits of Neonatal Screening for Cystic Fibrosis
Farrell, P. M., Kosorok, M. R., Laxova, A., Shen, G., Koscik, R. E., Bruns, W. T., Splaingard, M., & Mischler, E. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371403 · Cited by 388
Self-citation
Cited by
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908639 · Cited by 2,198
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
Farrell, P. M., White, T. B., Ren, C. L., Hempstead, S. E., Accurso, F., Derichs, N., Howenstine, M., McColley, S. A., Rock, M., Rosenfeld, M., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.09.064 · Cited by 953
Self-citationEffect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 807
Self-citationECFS best practice guidelines: the 2018 revision
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.006 · Cited by 765
Self-citationThe Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
Skin-Interfaced Wearable Sweat Sensors for Precision Medicine
Min, J., Tu, J., Xu, C., Lukas, H., Shin, S., Yang, Y., Solomon, S. A., Mukasa, D., & Gao, W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00823 · Cited by 712
Sosnay, P. R., Siklosi, K. R., Van Goor, F., Kaniecki, K., Yu, H., Sharma, N., Ramalho, A. S., Amaral, M. D., Dorfman, R., Zielenski, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2745 · Cited by 630
Self-citationConsensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice
Castellani, C., Cuppens, H., Macek, M., Cassiman, J. J., Kerem, E., Durie, P., Tullis, E., Assael, B. M., Bombieri, C., Brown, A., et al. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.03.009 · Cited by 601
Self-citationEuropean cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Davies, J. C., Wainwright, C. E., Canny, G. J., Chilvers, M. A., Howenstine, M. S., Munck, A., Mainz, J. G., Rodriguez, S., Li, H., Yen, K., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0153oc · Cited by 510
Skin-interfaced systems for sweat collection and analytics
Choi, J., Ghaffari, R., Baker, L. B., & Rogers, J. A. (2018) · Science Advances · doi:10.1126/sciadv.aar3921 · Cited by 433
Recommendations for the classification of diseases as CFTR-related disorders
Bombieri, C., Claustres, M., De Boeck, K., Derichs, N., Dodge, J., Girodon, E., Sermet, I., Schwarz, M., Tzetis, M., Wilschanski, M., et al. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60014-3 · Cited by 429
Self-citationCFTR: folding, misfolding and correcting the ΔF508 conformational defect
Lukacs, G. L., & Verkman, A. S. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.10.003 · Cited by 375
Non–Cystic Fibrosis Bronchiectasis
McShane, P. J., Naureckas, E. T., Tino, G., & Strek, M. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0411ci · Cited by 372
Choi, J., Bandodkar, A. J., Reeder, J. T., Ray, T. R., Turnquist, A., Kim, S. B., Nyberg, N., Hourlier-Fargette, A., Model, J. B., Aranyosi, A. J., et al. (2019) · ACS Sensors · doi:10.1021/acssensors.8b01218 · Cited by 365
MacKenzie, T., Gifford, A. H., Sabadosa, K. A., Quinton, H. B., Knapp, E. A., Goss, C. H., & Marshall, B. C. (2014) · Annals of Internal Medicine · doi:10.7326/m13-0636 · Cited by 355
Davies, J. C., Cunningham, S., Harris, W. T., Lapey, A., Regelmann, W. E., Sawicki, G. S., Southern, K. W., Robertson, S., Green, Y., Cooke, J., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00545-7 · Cited by 347
Knapp, E. A., Fink, A. K., Goss, C. H., Sewall, A., Ostrenga, J., Dowd, C., Elbert, A., Petren, K. M., & Marshall, B. C. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201511-781oc · Cited by 346
Managing Cystic Fibrosis: Strategies That Increase Life Expectancy and Improve Quality of Life
Cohen-Cymberknoh, M., Shoseyov, D., & Kerem, E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1478ci · Cited by 287
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
Waters, V., Stanojevic, S., Atenafu, E. G., Lu, A., Yau, Y., Tullis, E., & Ratjen, F. (2012) · European Respiratory Journal · doi:10.1183/09031936.00159111 · Cited by 256
“2 documented sweat chloride values > 60 mEq/L measured by quantitative pilocarpine iontophoresis test, genetic testing showing 2 CF- causing mutations or a nasal potential difference consistent with CF[11].”
MethodType of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic Fibrosis
Ooi, C. Y., Dorfman, R., Cipolli, M., Gonska, T., Castellani, C., Keenan, K., Freedman, S. D., Zielenski, J., Berthiaume, Y., Corey, M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.046 · Cited by 254
Self-citationCystic fibrosis: a clinical view
Castellani, C., & Assael, B. M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2393-9 · Cited by 254
Self-citationKwon, K., Kim, J. U., Deng, Y., Krishnan, S. R., Choi, J., Jang, H., Lee, K., Su, C.-J., Yoo, I., Wu, Y., et al. (2021) · Nature Electronics · doi:10.1038/s41928-021-00556-2 · Cited by 230
Stephenson, A. L., Sykes, J., Stanojevic, S., Quon, B. S., Marshall, B. C., Petren, K., Ostrenga, J., Fink, A. K., Elbert, A., & Goss, C. H. (2017) · Annals of Internal Medicine · doi:10.7326/m16-0858 · Cited by 192
Convertino, M., Das, J., & Dokholyan, N. V. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00195 · Cited by 105
Association Between Carrier Screening and Incidence of Cystic Fibrosis
Castellani, C. (2009) · JAMA · doi:10.1001/jama.2009.1758 · Cited by 96
Self-citationCoffey, M. J., Whitaker, V., Gentin, N., Junek, R., Shalhoub, C., Nightingale, S., Hilton, J., Wiley, V., Wilcken, B., Gaskin, K. J., et al. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.10.045 · Cited by 73
Prognostic value of six minute walk test in cystic fibrosis adults
Martin, C., Chapron, J., Hubert, D., Kanaan, R., Honoré, I., Paillasseur, J.-L., Aubourg, F., Dinh-Xuan, A.-T., Dusser, D., Fajac, I., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.10.001 · Cited by 63
“CF was diagnosed on the basis of clinical manifestations, sweat chloride concentrations and genetic findings [15].”
BackgroundMaintaining mental health and function for the long run in cystic fibrosis
Smith, B. A., Georgiopoulos, A. M., & Quittner, A. L. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23522 · Cited by 39
Metadata
- Authors
- Farrell, P. M., Rosenstein, B. J., White, T. B., Accurso, F. J., Castellani, C., Cutting, G. R., Durie, P. R., LeGrys, V. A., Massie, J., Parad, R. B., Rock, M. J., & Campbell, P. W.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 153
- Issue
- 2
- Pages
- S4-S14
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2062137132
- Cited by
- 1,094
- References
- 63
- FWCI
- 55.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.